83
Views
4
CrossRef citations to date
0
Altmetric
Original Article: Clinical

Serum thrombopoietin compared with ZAP-70 and immunoglobulin heavy-chain gene mutation status as a predictor of time to first treatment in early chronic lymphocytic leukemia

, , , , , , , & show all
Pages 62-67 | Received 03 Sep 2007, Accepted 20 Oct 2007, Published online: 01 Jul 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Tamar Tadmor & Aaron Polliack. (2011) Expanding the use of thrombopoietin mimetic drugs: what about chronic lymphocytic leukemia?. Leukemia & Lymphoma 52:4, pages 558-559.
Read now

Articles from other publishers (3)

Shimrit Ringelstein‐Harlev, Mona Fanadka, Netanel A. Horowitz, Noam P. Bettman & Tami Katz. (2022) In chronic lymphocytic leukemia, activation of the thrombopoietin receptor promotes T‐cell inhibitory properties, contributing to immunosuppression. European Journal of Haematology 110:4, pages 371-378.
Crossref
Nina Kreuzberger, Johanna AAG Damen, Marialena Trivella, Lise J Estcourt, Angela Aldin, Lisa Umlauff, Maria DLA Vazquez-Montes, Robert Wolff, Karel GM Moons, Ina Monsef, Farid Foroutan, Karl-Anton Kreuzer & Nicole Skoetz. (2020) Prognostic models for newly-diagnosed chronic lymphocytic leukaemia in adults: a systematic review and meta-analysis. Cochrane Database of Systematic Reviews 2020:7.
Crossref
Femke Van Bockstaele, Bruno Verhasselt & Jan Philippé. (2009) Prognostic markers in chronic lymphocytic leukemia: A comprehensive review. Blood Reviews 23:1, pages 25-47.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.